Effects of endothelin-1 on bacterial clearance in rabbits

European Journal of Anaesthesiology

Volumn 16, Issue 3, 1999, Pages 169-175

  Schmeck, J ^a   Heller, A ^a   Phan, T L H ^a   Urbschek, R ^a   Koch, T ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Experimental: rabbit, bacterial clearance, endothelin 1, sepsis

Indexed keywords

ENDOTHELIN 1; LACTIC ACID;

AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL IMMUNITY; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; FEMALE; KIDNEY; LACTATE BLOOD LEVEL; LIVER; LUNG; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RABBIT; SPLEEN;

ANIMALS; BLOOD PRESSURE; COLONY COUNT, MICROBIAL; ENDOTHELIN-1; ENDOTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMODYNAMIC PROCESSES; HEMOGLOBINS; KIDNEY; KINETICS; LACTIC ACID; LIPOPOLYSACCHARIDES; LIVER; LUNG; MALE; RABBITS; SPLEEN;

EID: 0032908355     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2346.1999.00445.x     Document Type: Article

References (38)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
2. Chalmers GW, Little SA, Patel KR, Thomson NC. Endothelin-1-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1997; 156: 382-388.
3. Halim A, Kanayama N, el Maradny E, Maehara K, Terao T. Activated neutrophil by endothelin-1 caused tissue damage in human umbilical cord. Thromb Res 1995; 77: 321-327.
4. Eguchi K, Kawakami A, Nakashima M, Ida H, Sakito S, Sakai M et al. Stimulation of mitogenesis in human thyroid epithelial cells by endothelin. Acta Endocrinol (Copenh) 1993; 128: 215-220.
5. Weitzberg E, Lundberg JM, Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 1991; 33: 222-227.
6. Sanai L, Haynes WG, MacKenzie A, Grant IS, Webb DJ. Endothelin production in sepsis and the adult respiratory distress syndrome, Intens Care Med 1996; 22: 52-56.
7. Takahashi K, Silva A, Cohen J, Lam HC, Ghatei MA, Bloom SR. Endothelin immunoreactivity in mice with gram-negative bacteraemia: relationship to tumour necrosis factor-alpha. Clin Sci 1990; 79: 619-623.
8. Lundblad R, Giercksky KE. Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats. Crit Care Med 1995; 23: 1382-1390.
9. Myhre U, Pettersen JT, Risoe C, Giercksky KE. Endothelin-1 and endotoxemia. J Cardiovasc Pharmacol 1993; 22 (Suppl. 8): S291-S294.
10. Kaddoura S, Curzen NP, Evans TW, Firth JD, Poole-Wilson PA. Tissue expression of endothelin-1 mRNA in endotoxaemia. Biochem Biophys Res Commun 1996; 218: 641-647.
11. Kaw S, Hecker M, Southan GJ, Warner TD, Vane JR. Characterization of serine protease-derived metabolites of big endothelin in the cytosolic fraction from human polymorphonuclear leucocytes. J Cardiovasc Pharmacol 1992; 20 (Suppl. 12): S22-S24.
12. Kaw S, Hecker M, Vane JR. The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leucocytes. Proc Natl Acad Sci USA 1992; 89: 6886-6890.
13. Schmeck J, Janzen R, Munter K, Neuhof H, Koch T. Endothelin-1 and thromboxane A2 increase pulmonary vascular resistance in granulocyte mediated lung injury. Crit Care Med 1998; 26: 1868-1874.
14. Masaki T, Yanagisawa M. Cardiovascular effects of the endothelins. Cardiovasc Drug Rev 1990; 8: 373-385 .
15. Pittet JF, Morel DR, Hemsen A, Gunning K, Lacroix JS, Suter P et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991; 213: 261-264.
16. Sandys GH. A new method of preventing swarming of Proteus sp. with a description of a new medium suitable for use in routine laboratory practice. J Med Lab Technol 1960; 17: 224-233.
17. Koch T, Duncker HP, Axt R, Schiefer HG, Van Ackern K, Neuhof H. Effects of hemorrhage, hypoxia, and intravascular coagulation on bacterial clearance and translocation. Crit Care Med 1993; 21: 1758-1764.
18. Koch T, Duncker HP, Axt R, Schiefer HG, van Ackern K, Neuhof H. Alterations of bacterial clearance induced by endotoxin and tumour necrosis factor. Infect Immun 1993; 61: 3143-3148.
19. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
20. Zweifach BW, Benacerraf B, Thomas L. The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage. II. The possible role of the reticuloendothelial system in resistance to each type of shock. J Exp Med 1957; 106: 403-414.
21. Fine J, Ruthenberg S, Schweinburg FB. The role of the reticuloendothelial system in hemorrhagic shock. J Exp Med 1959; 110: 547-569.
22. Abraham E, Chang YH. Effects of hemorrhage on inflammatory response. Arch Surg 1987; 119: 1154-1157.
23. Fink MP, Gardiner M, MacVittie TJ. Sublethal hemorrhage impairs acute peritoneal response in rats. J Trauma 1985; 25: 234-237.
24. Baker JW, Deitch EA, Berg RD, Specian RD. Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 1988; 28: 94-101.
25. Schmeck J, Heller A, Koch T. Pathophysiologic impact of the vasoactive peptide endothelin. Anesthesiol Neokl Pece 1997; 4: 149-152.
26. Barnes PJ. Endothelins and pulmonary diseases. J Appl Physiol 1994; 77: 1051-1059.
27. Schmeck J, Janzen R, van Ackern K, Koch T. The influence of endothelin-1 and thromboxane A2 in PMN-mediated inflammatory reaction in the lung. Br J Anaesth 1997; 78 (Suppl. 1): S39.
28. King AJ, Brenner BM, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989; 256: F1051-F1058.
29. Wallace JL, Cirino G, De Nucci G, McKnight W, MacNaughton WK. Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. Am J Physiol 1989; 256: G661-G666.
30. Miyauchi T, Tomobe Y, Shiba R, Ishikawa T, Yanagisawa M, Kimura S et al. Involvement of endothelin in the regulation of human vascular tonus. Potent vasoconstrictor effect and existence in endothelial cells. Circulation 1990; 81: 1874-1880.
31. Lippton HL, Pellett A, Cairo J, Summer WR, Lowe RF, Sander GE et al. Endothelin produces systemic vasodilatation independent of the state of consciousness. Peptides 1989; 10: 939-943.
32. Pernow J, Boutier JF, Franco-Cereceda A, Lacroix JS, Matran R, Lundberg JM. Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivo. Acta Physiol Scand 1988; 134: 573-574.
33. Barnard JW, Barman SA, Adkins WK, Longenecker GL, Taylor AE. Sustained effects of endothelin-1 on rabbit, dog, and rat pulmonary circulations. Am J Physiol 1991; 261: H479-H486.
34. Ahlborg G, Weitzberg E, Lundberg JM. Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans. J Appl Physiol 1995; 79: 141-145.
35. Lopez Farre A, Riesco A, Espinosa G, Digiuni E, Cernadas MR, Alvarez V et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993; 88: 1161-1171.
36. Filep JG, Fournier A, Foldes-Filep E. Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors. Br J Pharmacol 1995; 115: 227-236.
37. McMillen MA, Huribal M, Kumar R, Sumpio BE. Endothelin-stimulated human monocytes produce prostaglandin E2 but not leukotriene B4. J Surg Res 1993; 54: 331-335.
38. McMillen MA, Sumpio BE. Endothelins: polyfunctional cytokines. J Am Coll Surg 1995; 180: 621-637.